NEUROCEUTICAL Trademark

Pharmaceutical and biologically active compositions incorporating neurotechnology for cognitive, neurological, or physiological modulation. Includes compounds or preparations delivered by ingestion, injection, inhalation, topical contact, implantation, or passive exposure through air, water, food, or skin. Covers formulations responsive to electromagnetic fields, radiofrequency, or wireless signals, including current and future networks such as 5G, 6G, or satellite-linked systems. Neuroceuticals may include nanotechnology, such as nanoparticles, nanobots, or neural dust, designed to interface with the human nervous system. Includes both voluntary and passive administration, and may function independently or in combination with AI, biometric systems, or remote neural monitoring platforms.